Strategic partner

Global commercialization and development collaboration

We have signed a global, strategic collaboration agreement to develop and commercialise SHP2 inhibitors with AbbVie on June 1, 2020.

Click here to know more about our partnership.

Cutting-edge therapy partners

Using the latest research to bring hope to patients

Click here to know more about our partnership.

Artificial intelligence partners

Helping with early drug discovery

CRO/CDMO collaboration partners

Collaborations in drug R&D

We look forward to working with you to advance drug development and commercialization

With an experienced business team with deep understanding of the Chinese and global markets, Jacobio has worked with many well-known international companies to foster drug development and commercialization.

In the future, we will focus on the next generation of cutting-edge technologies that can lead to breakthrough therapies for patients around the world.

If you are interested in partnering with Jacobio, please contact us at: